MoneyWorks4Me

Colinz Laboratories - Quaterly Results

16 May 2025 Evaluate
The sales for the March 2025 quarter moved down to Rs. 14.51 millions as compared to Rs. 16.29 millions during the year-ago period.The Company has registered profit of Rs. 1.50  millions for the quarter ended March 2025, a growth of 11.94%  over Rs. 1.34 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended March 2025 decreased to 1.74 millions as compared to 2.31 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 14.51 16.29 -10.93 65.28 70.30 -7.14 65.28 70.30 -7.14
Other Income 0.76 1.07 -28.97 2.98 2.75 8.36 2.98 2.75 8.36
PBIDT 1.74 2.31 -24.68 7.94 8.17 -2.82 7.94 8.17 -2.82
Interest 0.16 0.10 60.00 0.42 0.37 13.51 0.42 0.37 13.51
PBDT 1.58 2.21 -28.51 7.52 7.80 -3.59 7.52 7.80 -3.59
Depreciation 0.35 0.33 6.06 1.31 1.30 0.77 1.31 1.30 0.77
PBT 1.23 1.88 -34.57 6.21 6.50 -4.46 6.21 6.50 -4.46
TAX -0.27 0.54 -150.00 1.23 1.64 -25.00 1.23 1.64 -25.00
Deferred Tax -0.52 -0.02 2500.00 -0.52 -0.02 2500.00 -0.52 -0.02 2500.00
PAT 1.50 1.34 11.94 4.98 4.86 2.47 4.98 4.86 2.47
Equity 25.19 25.19 0.00 25.19 25.19 0.00 25.19 25.19 0.00
PBIDTM(%) 11.99 14.18 -15.44 12.16 11.62 4.66 12.16 11.62 4.66
Peers
Company Name CMP
Sun Pharma. Inds. 1873.20
Dr. Reddys Labs. 1208.00
Cipla 1384.55
Lupin 2111.00
Zydus Lifesciences 1158.20
View more..